Market Overview

Pint Of No Return: Weighing The Impact Of Trial Between Molson Coors, Pabst

Pint Of No Return: Weighing The Impact Of Trial Between Molson Coors, Pabst
Related TAP
7 Companies That Entered The Cannabis Space In 2018
Thinking About Launching A Cannabis Consumer Product? Here's What You Should Know
Dodge & Cox Buys CVS Health Corp, Booking Holdings Inc, Microchip Technology Inc, Sells UBS ... (GuruFocus)

With Pabst and Molson Coors Brewing Co (NYSE: TAP) facing off in court, BMO Capital Markets considered the implications for the beer industry.

The Analyst

Analyst Amit Sharma reiterated a Outperform rating on Molson Coors with an $85 price target.

The Thesis

The trial has the potential to have a substantial and immediate influence on Molson Coors’ cost and margin structure, Sharma said in a Tuesday note. (See his track record here.)

“The best-case scenario for TAP, in our view, would be a full exit from its current co-packing arrangement with Pabst, enabling TAP to cease production of low-margin contract beer and perhaps further optimize its U.S. brewery footprint by shuttering an additional brewery.”

The core of the trial revolves around the imminent expiration of the companies’ market agreement, in which MillerCoors brews Pabst products. Several outcomes are possible, the analyst said, listing them in order of their favorability for MillerCoors:

  • The complete exit from the agreement upon its June 2022 expiration, “enabling TAP to optimize its U.S. brewery footprint by potentially closing another brewery. Removing Pabst volume would likely be a $90-100 million hit to revenues, but given unfavorable margins, it would have minimal impact on earnings," Sharma said.
  • Increasingly favorable rates for the continued brewing of Pabst products. Up to roughly $130 million could be added to incremental revenue through this initiative, the analyst said.
  • The continued brewing of Pabst products at poor rates plus the risk of punitive damages, as Pabst is seeking $400 million, Sharma said. "That said, given that our estimates are based on TAP's current product mix, continuation of the status quo would not have any impact on our current margin outlook.”

Price Action

Molson Coors shares were down 2.31 percent at $64.88 at the close Tuesday.

Related Links:

Molson Coors Expects To Launch Cannabis Beverage In 2019

RBC To Investors: This Bud's For You

Latest Ratings for TAP

Nov 2018CitigroupMaintainsBuyBuy
Oct 2018Standpoint ResearchInitiates Coverage OnBuy
Sep 2018GuggenheimInitiates Coverage OnNeutral

View More Analyst Ratings for TAP
View the Latest Analyst Ratings

Posted-In: Amit Sharma Beer BMO Capital MarketsAnalyst Color Price Target Reiteration Top Stories Analyst Ratings Best of Benzinga


Related Articles (TAP)

View Comments and Join the Discussion!

Latest Ratings

CMAB. Riley FBRDowngrades84.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

5 Stocks Moving In Monday's After-Hours Session

With 'Archetypes', Cannabis Industry Meets Customers In The Open Market